Your browser doesn't support javascript.
loading
Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production.
Semplici, Francesca; Mondragon, Angeles; Macintyre, Benedict; Madeyski-Bengston, Katja; Persson-Kry, Anette; Barr, Sara; Ramne, Anna; Marley, Anna; McGinty, James; French, Paul; Soedling, Helen; Yokosuka, Ryohsuke; Gaitan, Julien; Lang, Jochen; Migrenne-Li, Stephanie; Philippe, Erwann; Herrera, Pedro L; Magnan, Christophe; da Silva Xavier, Gabriela; Rutter, Guy A.
Afiliación
  • Semplici F; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Mondragon A; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Macintyre B; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Madeyski-Bengston K; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • Persson-Kry A; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • Barr S; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • Ramne A; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • Marley A; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • McGinty J; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • French P; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • Soedling H; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • Yokosuka R; AstraZeneca R&D, Alderley Edge, UK.
  • Gaitan J; Photonics Group, Department of Physics, Imperial College London, London, UK.
  • Lang J; Photonics Group, Department of Physics, Imperial College London, London, UK.
  • Migrenne-Li S; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Philippe E; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Herrera PL; Université de Bordeaux, Institut de Chimie et Biologie des Membranes et des Nano-objets, CNRS UMR 5248, Pessac, France.
  • Magnan C; Université de Bordeaux, Institut de Chimie et Biologie des Membranes et des Nano-objets, CNRS UMR 5248, Pessac, France.
  • da Silva Xavier G; Paris Diderot University, Unit of Functional and Adaptive Biology (BFA), CNRS UMR 8251, Paris, France.
  • Rutter GA; Paris Diderot University, Unit of Functional and Adaptive Biology (BFA), CNRS UMR 8251, Paris, France.
Diabetologia ; 59(9): 1938-47, 2016 09.
Article en En | MEDLINE | ID: mdl-27338626

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Serina-Treonina Quinasas / Células Secretoras de Glucagón / Células Secretoras de Insulina Límite: Animals Idioma: En Revista: Diabetologia Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Serina-Treonina Quinasas / Células Secretoras de Glucagón / Células Secretoras de Insulina Límite: Animals Idioma: En Revista: Diabetologia Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania